The Changing Environment Around Accelerated Approvals and Regulatory Pathways
PharmaTalkRadio7 Okt 2022

The Changing Environment Around Accelerated Approvals and Regulatory Pathways

In this session recorded at CMO Summit 2022, panelists share strategy trends and opportunities around accelerated approvals and regulatory designations. Additionally, they discuss: How to approach the FDA based on the different types of meetingsHow these trends and pathways affect trial designImplications after approval based on the pathway Speakers: Edith Perez, MD, CMO, Bolt BiotherapeuticsJeffrey Bornstein, MD, CMO, Eledon PharmaceuticalsAmy Blawas, PhD, Principal Consultant, NDA Group

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
rekommandert
liberal-halvtime
sinnsyn
forskningno
villmarksliv
rss-overskuddsliv
tomprat-med-gunnar-tjomlid
kvinnehelsepodden
rss-paradigmepodden
dekodet-2
rss-zahid-ali-hjelper-deg
rss-rekommandert
rss-inn-til-kjernen-med-sunniva-rose
hva-er-greia-med
psykopoden
rss-lundqvist-podden
tidlose-historier